INDOCO — INDOCO REMEDIES Cashflow Statement
0.000.00%
- IN₹21.30bn
- IN₹29.19bn
- IN₹18.17bn
- 54
- 27
- 47
- 37
Annual cashflow statement for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 286 | 1,320 | 2,366 | 1,928 | 1,243 |
Depreciation | |||||
Non-Cash Items | 287 | 366 | 81.7 | 503 | 572 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -52.4 | -1,595 | -1,499 | -1,348 | -1,160 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,228 | 822 | 1,738 | 1,788 | 1,573 |
Capital Expenditures | -585 | -768 | -1,253 | -2,073 | -4,273 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 25.3 | 102 | 39.2 | -9.22 | -65.2 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -559 | -667 | -1,214 | -2,082 | -4,338 |
Financing Cash Flow Items | -223 | -232 | -150 | -272 | -361 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -639 | -299 | -444 | 228 | 2,804 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 29.7 | -143 | 80.5 | -65.3 | 39.3 |